Table 3.
Univariate analysis of prognostic factors
| Variate | n | 2‐y OS (%) |
|---|---|---|
| Age (y) | ||
| ≥55 | 97 | 25 |
| <55 | 226 | 31 |
| Sex | ||
| Male | 286 | 26 |
| Female | 37 | 41 |
| Tumor size (cm) | ||
| <10 | 196 | 25 |
| ≥10 | 127 | 19 |
| Tumor number | ||
| <3 | 236 | 28 |
| ≥3 | 87 | 17 |
| HBsAg | ||
| + | 282 | 26 |
| − | 41 | 29 |
| AFP (ng/mL) | ||
| ≥400 | 166 | 29 |
| <400 | 157 | 32 |
| Child‐Pugh class | ||
| A | 303 | 31 |
| B | 20 | 15 |
| Cirrhosis | ||
| Yes | 241 | 27 |
| No | 82 | 33 |
| PVTT type | ||
| I/II | 224 | 38 |
| III | 99 | 12 |
| TACE | ||
| Yes | 184 | 32 |
| No | 139 | 18 |
| Treatment | ||
| RT | 134 | 25 |
| HR | 189 | 45 |
AFP: α‐fetoprotein; HBsAg: hepatitis B surface antigen; PVTT: portal vein tumor thrombus; TACE: transcatheter arterial chemoembolization.